UBS Group set a €87.00 ($103.57) price objective on Fresenius Medical Care AG & Co. (Pref) (ETR:FME) in a research note published on Thursday morning, www.boersen-zeitung.de reports. The brokerage currently has a neutral rating on the stock.

Other equities research analysts also recently issued reports about the company. Kepler Capital Markets set a €95.00 ($113.10) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the stock a buy rating in a report on Thursday, November 2nd. Deutsche Bank set a €83.00 ($98.81) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the company a neutral rating in a research report on Friday, October 20th. Berenberg Bank set a €95.60 ($113.81) price objective on Fresenius Medical Care AG & Co. (Pref) and gave the company a buy rating in a research report on Wednesday, December 6th. JPMorgan Chase & Co. set a €95.10 ($113.21) price target on Fresenius Medical Care AG & Co. (Pref) and gave the stock a buy rating in a report on Wednesday, October 11th. Finally, Goldman Sachs Group set a €97.00 ($115.48) price target on Fresenius Medical Care AG & Co. (Pref) and gave the stock a buy rating in a report on Monday, October 30th. Ten investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Fresenius Medical Care AG & Co. (Pref) currently has a consensus rating of Hold and an average target price of €90.17 ($107.34).

Fresenius Medical Care AG & Co. (ETR:FME) opened at €90.50 ($107.74) on Thursday. Fresenius Medical Care AG & Co. has a twelve month low of €73.87 ($87.94) and a twelve month high of €90.50 ($107.74). The firm has a market capitalization of $27,880.00 and a price-to-earnings ratio of 22.18.

ILLEGAL ACTIVITY WARNING: This news story was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another site, it was illegally copied and reposted in violation of U.S. and international trademark and copyright legislation. The correct version of this news story can be accessed at https://www.watchlistnews.com/fresenius-medical-care-ag-87-00-by-ubs-group/1798200.html.

Fresenius Medical Care AG & Co. (Pref) Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. (Pref) (ETR:FME)

Receive News & Ratings for Fresenius Medical Care AG & Co. (Pref) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. (Pref) and related companies with Analyst Ratings Network's FREE daily email newsletter.